Ā | Active group (nā=ā25) | Sham group (nā=ā11) | p-value |
---|---|---|---|
Age (years) | 47.88āĀ±ā14.8 | 41.60āĀ±ā14.9 | 0.266a |
Gender | |||
Ā Male | 20 (80%) | 7 (63.63%) | 0.409b |
Ā Female | 5 (20%) | 4 (36.36%) | |
Disorders | |||
Ā CVS | 17 (68%) | 6 (54.55%) | 0.344c |
Ā MS | 3 (12%) | 1 (9.09%) | |
Ā SCI | 4 (16%) | 1 (9.09%) | |
Ā Other | 1 (4%) | 3 (27.27%) | |
Ā Duration (months) | 42.74āĀ±ā52.74 | 64.09āĀ±ā67.07 | 0.175d |
Ā | Active (Nā=ā76) | Sham (Nā=ā44) | p-value |
---|---|---|---|
Baseline mAS | 2.83āĀ±ā0.78 | 2.8āĀ±ā0.79 | 0.982d |
Baseline eBTD | 83.14āĀ±ā47.27 | 85.68āĀ±ā46.15 | 0.723d |